Andreas Katopodis

Andreas was a Director in the Autoimmunity, Transplantation & Inflammation group at the Novartis Institutes for BioMedical Research. In this position, he was involved in many aspects of early to late drug development for immune-mediated diseases, taking several modalities to clinical trial and late stage development. He also supported multiple deals with startups. Prior to this, he worked at the Central Research Laboratories at Ciba Geigy, doing research on immune cell trafficking. Andreas studied Biochemistry and Molecular Biology and started his career as a faculty member at the Georgia Institute of Technology.